Dividends CalendarEarnings Calendar
ABBV

ABBV | AbbVie Inc

85.09 -4.42 (-5.48%) 

Did you Know:

AbbVie Inc. is the world's sixth-largest independent biotech company by market cap ($146.3 B).

AbbVie Inc

Company profile

  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Headquarters:   North Chicago, Illinois, United States
  • Number of employees::   30,000
Homepage : abbvie.com

Company profile

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases

About the Company

AbbVie is a pharmaceutical company that discovers, develops and markets both biopharmaceuticals and small molecule drugs. It originated in 2013 as a spin-off of Abbott Laboratories.

  • Subsidiaries:   Allergan, Pharmacyclics, Stemcentrx, Inc.
  • Revenue: 28.22 billion USD (2017)

Address

1 North Waukegan Road
North Chicago, IL 60064
United States

Products & Services

  • Pharmaceutical drugs

  • Humira (adalimumab)

  • Imbruvica (ibrutinib)

  • Venclexta (venetoclax)

  • Zinbryta (daclizumab)

  • Kaletra (lopinavir)

  • Norvir (ritonavir)

  • Mavyret/Maviret (glecaprevir/pibrentasvir)

  • Total Assets:   59.35 billion USD (2018)
  • Net Income :  Net income: 5.687 billion USD (2018)

Key Persons / Board of Directors

  • CEO :  Richard A. Gonzalez
  • CFO :  Robert A. Michael

Videos about AbbVie Inc



Jump to (Finance sites)

Their Official Profiles 

WikipediaTwitterFacebookLinkedInInstagramYoutube

Peers / Similar stocks 

xlv biib pfe amgn gild lly bmy 

Other stocks 

crm rht tjx lb bac swn mrk azo ctas tal cgc once 

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media 




Recommended Books

Investing For Dummies
Buy on Amazon

In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.